President Trump Signs Executive Order on Psychedelic Therapy Research
President Trump signed an executive order to expand research into psychedelic therapies. The order follows state-level actions in Texas and Mississippi on ibogaine access.
Washington ExaminerPresident Donald Trump signed an executive order to increase research into psychedelic therapies. The order comes after Texas passed ibogaine legislation last year and Mississippi state Rep. Sam Creekmore sponsored a bill signed into law by Gov. Tate Reeves weeks ago.
A combat veteran who served five deployments as an Army Ranger described receiving ibogaine treatment in Mexico in 2019 after standard veterans' healthcare options did not fully address his depression and migraines. He reported that the treatment reduced his chronic depression and migraines within a week and provided clarity that helped him rebuild aspects of his personal and professional life.
Ibogaine remains illegal at the federal level, which has limited domestic research for decades.
The veteran stated that people currently travel abroad for treatment in settings with varying levels of medical oversight. He called for research on best practices, safety protocols, and heart health monitoring before wider use. The article notes that proper screening and clinical standards could reduce risks compared with current overseas options.
